DARs are a snap with IDEA


View IDEA Demo

Improve patient safety

standardized processes for managing investigational product to improve patient safety while maintaining regulatory compliance

safeguards to prevent selection for dispensing of expired or quarantined agents

reduce the risk of dispensing to patients not enrolled on a study

Benefits of centralized inventory management

Centralized electronic management of investigational products offers improved legibility, reduced paperwork/handwriting and streamlined inventory management to provide pharmacists more time for valuable work and patient care

Provides standardized DARFs with sections for required transactions (receipt, dispensing, returns and disposition) to ensure consistency and compliance with applicable regulations. DARFs can be customized using filters, but still maintain a standard appearance for all protocols regardless of sponsor

Automates processes to provide accurate management and documentation of investigational product receipt, storage, dispensing, returns and final disposition, which in turn improves overall investigational pharmacy effectiveness.document storage and access

 Provides common access to protocol, patient and investigational product information, eliminating duplicate or multiple spreadsheets maintained by individual users - time savings for staff and elimination of paper record keeping greatly reduces waste.


Order and receive agent

Permits the ordering of investigational agents to be aligned with the patient and protocol using a variety of scalable order forms, email, and online ordering. Able to track processed orders via Agent Ordering report (queue).

Upon receival records agent details, including exact date/time received, pharmacy generated lot numbers, container type, quantity, unit, method, packaging, supplying agency, storage location, etc.

Updates Drug Accountability Records (DARs) and notifies the requesting individual of agent arrival.




invoicing, sponsor payment tracking and allocation

manage study start-up costs

track money paid out to third-parties

complete reporting

tools for managing billing compliance, financial analysis and MCA creation


Staff time and effort tracking

manage staff tasks and time spent on task

report workload data

Oncology expertise

In 1997 DDOTS began working on the development of pharmacy management software for institutions participating in National Cancer Institute trials. Collaboration with members of the NCI's Pharmacy Management Branch at that time enhanced DDOTS' understanding of the NCI's issues and future direction required for investigational drug management systems.

IDEA incorporates numerous elements to manage the entire process of drug ordering and dispensing, drug tracking and NCI reporting. For example:

The Drug Order Module permits the ordering of a drug to be aligned with the patient and protocol.

The Receive Agent Module updates drugs on order, identifies those back-ordered and updates the DARs in NCI format.

The Transfer Module allows the potential to transfer drugs among protocols and locations and then evaluates the ramifications of a transfer on inventory. This capability was of particular interest to the NCI in order to streamline or eliminate the process of shipping, returning and re-shipping investigational drugs.

The Returns Module tracks drugs returned to the NCI with email available for notification of returns, including NCI return authorization numbers.

A comprehensive Reports Module includes an accountability report through which the NCI and/or research bases can perform random audits of research site drug usage and inventories.


Another headline

And an even wittier subheading.


Another headline

And an even wittier subheading.